A Study of LY03003 in Patients With Early-stage Parkinson's Disease

NCT04044547 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Rotigotine, extended-release microspheres
DRUG: Placebo, extended-release microspheres

Sponsor

Luye Pharma Group Ltd.

Collaborators

[object Object]